ArticleJournal of molecular histology2025
Helicobacter pylori VacA-induced gastric mucosal atrophy: a comparative analysis with other forms of atrophic gastritis.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the atrophic changes induced by Helicobacter pylori VacA and compare them with other forms of atrophic gastritis.A comprehensive histomorphological analysis and immunohistochemical evaluation were performed on 984 endoscopic gastric mucosal biopsy samples from patients with endoscopically confirmed atrophic gastritis. H. pylori primarily adheres to surface mucus cells, where it proliferates and produces the vacuolating cytotoxin VacA. The underlying mechanism involves VacA inducing the upward migration and compensatory proliferation of cells located in the deeper regions of gastric pits, the isthmus of gastric glands, and the neck mucous cells, ultimately leading to gastric atrophy. In this study, a comparative analysis was performed with autoimmune atrophy, degenerative denaturation atrophy, drug-induced atrophy, and non-specific atrophy. Both clinical and histological characteristics were evaluated, and pathological diagnostic criteria for mucosal atrophy were proposed for the first time. Of the 984 cases examined, H. pylori-induced atrophic gastritis was identified in 648 cases, accounting for 65.9% (648/984); autoimmune atrophy in 34 cases, representing 3.5% (34/984); degenerative denaturation atrophy in 59 cases, representing 6.0% (59/984); drug-induced atrophy in 72 cases, making up 7.3% (72/984); and non-specific atrophy in 171 cases, accounting for 17.4% (171/984). H. pylori infection was found to be associated with a high prevalence of infectious atrophy, accompanied by active epithelial cell proliferation, intraepithelial neoplasia, early changes in mucosa-associated lymphoid tissue lymphoma, and cell proliferation outside the lymphatic follicular mantle. The comparative analysis of gastric mucosal atrophy induced by H. pylori VacA, in comparison to other forms of atrophic gastritis, is crucial for understanding the pathogenesis of gastric cancer and improving management strategies for its prevention and progression.
Indexed as
Identifiers
40455334What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.